Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC

INTRODUCTION: Radiological response assessment to immune checkpoint inhibitor is challenging due to atypical pattern of response and commonly used RECIST 1.1 criteria do not take into account the kinetics of tumor behavior. Our study aimed at evaluating the tumor growth rate (TGR) in addition to REC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dall’Olio, Filippo G., Parisi, Claudia, Marcolin, Laura, Brocchi, Stefano, Caramella, Caroline, Conci, Nicole, Carpani, Giulia, Gelsomino, Francesco, Ardizzoni, Stefano, Marchese, Paola Valeria, Paccapelo, Alexandro, Grilli, Giada, Golfieri, Rita, Besse, Benjamin, Ardizzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842375/
https://www.ncbi.nlm.nih.gov/pubmed/35173818
http://dx.doi.org/10.1177/17588359211058391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842375/
https://www.ncbi.nlm.nih.gov/pubmed/35173818
http://dx.doi.org/10.1177/17588359211058391

Ejemplares similares